These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26177989)

  • 1. Transfusion service management of sickle-cell disease patients.
    Yazer MH; Lozano M; Crighton G; Greenway A; Comande M; Savoia H; Wood E; Gilli S; Castilho L; Saad ST; Galactéros F; Noizat-Pirenne F; Pazgal I; Stark P; Orlin Y; Perseghin P; Masera N; Cela E; Anguita J; Wikman A; Delaney M
    Vox Sang; 2016 Apr; 110(3):288-94. PubMed ID: 26177989
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of red blood cell alloimmunization risk reduction.
    Karafin MS; Denomme GA; Bryant BJ
    Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective antigen matching strategies fail to fit the model.
    Webb J; Chou ST
    Transfusion; 2015 Jan; 55(1):221-2. PubMed ID: 25582239
    [No Abstract]   [Full Text] [Related]  

  • 4. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-transfusion phenotype matching for sickle cell disease patients.
    Afenyi-Annan A; Brecher ME
    Transfusion; 2004 Apr; 44(4):619-20. PubMed ID: 15043582
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of red blood cell alloimmunization risk reduction.
    Kacker S; Ness PM; Shirey RS; Savage WJ; King KE; Tobian AA
    Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240
    [No Abstract]   [Full Text] [Related]  

  • 7. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
    Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.
    Harm SK; Yazer MH; Monis GF; Triulzi DJ; Aubuchon JP; Delaney M
    Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How we incorporate molecular typing of donors and patients into our hospital transfusion service.
    Shafi H; Abumuhor I; Klapper E
    Transfusion; 2014 May; 54(5):1212-9. PubMed ID: 24628032
    [No Abstract]   [Full Text] [Related]  

  • 10. Sickle cell patients deserve controlled recommendations.
    Strauss RG
    Transfusion; 2002 May; 42(5):658-9; author reply 659-60. PubMed ID: 12084176
    [No Abstract]   [Full Text] [Related]  

  • 11. Children's National Medical Center's transfusion protocol for sickle hemoglobinopathies.
    Minniti CP; Kratovil T; Luban NL
    Immunohematology; 2006; 22(3):117-20. PubMed ID: 17105359
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: clinical transfusion management in sickle cell disease.
    Rogers ZR
    Immunohematology; 2006; 22(3):126-31. PubMed ID: 17105361
    [No Abstract]   [Full Text] [Related]  

  • 14. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria.
    Ugwu NI; Awodu OA; Bazuaye GN; Okoye AE
    Niger J Clin Pract; 2015; 18(4):522-6. PubMed ID: 25966726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood transfusion in sickle cell disease.
    Davies SC; Roberts-Harewood M
    Blood Rev; 1997 Jun; 11(2):57-71. PubMed ID: 9242989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To match or not to match: the question for chronically transfused patients with sickle cell anemia.
    Ness PM
    Transfusion; 1994 Jul; 34(7):558-60. PubMed ID: 8053035
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion therapy for sickle cell disease: a balancing act.
    Chou ST
    Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia.
    Sesok-Pizzini DA; Friedman DF; Smith-Whitley K; Nance SJ
    Immunohematology; 2006; 22(3):121-5. PubMed ID: 17105360
    [No Abstract]   [Full Text] [Related]  

  • 20. Regular automated red cell exchange transfusion in the management of stuttering priapism complicating sickle cell disease.
    Ekong A; Berg L; Amos RJ; Tsitsikas DA
    Br J Haematol; 2018 Feb; 180(4):585-588. PubMed ID: 27723091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.